FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Roberto Pisoni

Research Profile

Chemicals & Drugs

Physiology

Disorders

Procedures

Kidney Function Tests

Phenomena

Renal Plasma Flow

Concepts & Ideas

Co-author Network

Publications

TOP 3
Piero Ruggenenti; Naobumi Mise; Roberto Pisoni; Federica Arnoldi; Anna Pezzotta; Annalisa Perna; Dario Cattaneo; Giuseppe Remuzzi
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.
Roberto Pisoni; Claudio Aros; Piero Ruggenenti; Giuseppe Remuzzi
Mechanisms of progression of chronic renal disease.
Roberto Pisoni; Rita Faraone; Piero Ruggenent; Giuseppe Remuzzi
Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Roberto Pisoni (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Piero Ruggenenti; Naobumi Mise; Roberto Pisoni; Federica Arnoldi; Anna Pezzotta; Annalisa Perna; Dario Cattaneo; Giuseppe Remuzzi
Diverse effects of increasing lisinopril doses on lipid abnormalities in chronic nephropathies.
Circulation 2003;107(4):586-92.
2002: Roberto Pisoni; Claudio Aros; Piero Ruggenenti; Giuseppe Remuzzi
Mechanisms of progression of chronic renal disease.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia 2002;13(3):250-6.
2002: Roberto Pisoni; Rita Faraone; Piero Ruggenent; Giuseppe Remuzzi
Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
Journal of nephrology 2002;15(4):428-30.
2000: Piero Ruggenenti; Annalisa Perna; Mariadomenica Lesti; Roberto Pisoni; L Mosconi; Federica Arnoldi; I Ciocca; Flavio Gaspari; Giuseppe Remuzzi
Pretreatment blood pressure reliably predicts progression of chronic nephropathies. GISEN Group.
Kidney international 2000;58(5):2093-101.
2000: Roberto Pisoni; Giuseppe Remuzzi
How much must blood pressure be reduced in order to obtain the remission of chronic renal disease?
Journal of nephrology 2000;13(3):228-31.
1998: Flavio Gaspari; Norberto Perico; Roberto Pisoni; MF Anedda; O Signorini; R Caruso; Eliana Gotti; Giuseppe Remuzzi
How to convert from traditional cyclosporine to the microemulsion formulation in stable renal transplant patients?
Clinical transplantation 1998;12(5):379-90.
1998: Piero Ruggenenti; Annalisa Perna; L Mosconi; Roberto Pisoni; Giuseppe Remuzzi
Urinary protein excretion rate is the best independent predictor of ESRF in non-diabetic proteinuric chronic nephropathies. "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Kidney international 1998;53(5):1209-16.
1997: Piero Ruggenenti; Annalisa Perna; L Mosconi; M Matalone; Roberto Pisoni; Flavio Gaspari; Giuseppe Remuzzi
Proteinuria predicts end-stage renal failure in non-diabetic chronic nephropathies. The "Gruppo Italiano di Studi Epidemiologici in Nefrologia" (GISEN).
Kidney international. Supplement 1997;63():S54-7.